Apeiron Synthesis stands at the forefront of industrial olefin metathesis, delivering innovative catalytic solutions that transform chemical manufacturing across diverse global sectors. Founded in 2009, Apeiron harnesses Nobel Prize-winning technology to redefine the possibilities of sustainable and cost-effective chemical transformation. Our team of dedicated R&D specialists and experienced professionals is passionate about developing robust ruthenium-based catalysts and providing end-to-end services that cater to the real needs of the chemical industry.
At Apeiron Synthesis, we empower our clients to optimize processes in pharmaceuticals, polymers, specialty chemicals, and renewable materials. Our expertise extends from catalyst design and process optimization to custom manufacturing and large-scale project delivery. Each catalyst is engineered for outstanding selectivity, efficiency, and stability, supporting advanced applications such as cross metathesis, ring-closing metathesis, ROMP, and ethenolysis. This enables industrial partners to achieve superior yields, greater process simplicity, and alignment with modern green chemistry standards.
Collaborating with international partners, Apeiron ensures tailored support from initial screening to multi-kilogram production, streamlining the pathway from discovery to commercialization. With a strong portfolio of granted patents and a commitment to scientific innovation, we have successfully served clients worldwide, delivering proven results that elevate chemical synthesis to new levels of sustainability and profitability. Explore the potential of olefin metathesis for your business with Apeiron Synthesis — your trusted partner in industrial catalysis and transformative process engineering.